TITLE

Burkholderia cepacia y enfermedad granulomatosa crónica. Informe de un caso

AUTHOR(S)
Gamboa-Salcedo, Tamara; Cardoso-Hernández, Gabriel; Saucedo-Ramírez, Omar Josué; Peña-Alonso, Yolanda Rocío
PUB. DATE
January 2009
SOURCE
Boletin Medico del Hospital Infantil de Mexico (Departamento de ;ene/feb2009, Vol. 66 Issue 1, p68
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Introduction. Chronic granulomatous disease (CGD) is an immunodeflciency characterized by a defect of phagocitosis, so initial manifestations are those from the secondary infection. It is an uncommon disease, whose diagnosis is always a challenge. Case report. The case of a previously healthy boy who came to the hospital with fever of unknowns origin is presented. He was diagnosed with persistent pneumonia that required decortication. Burkholderia cepacia grew from the lung biopsy culture. Because this bacteria has been related to immunodeficient patients, screening for immunodeficiency were performed and the diagnosis of CGD was established. Conclusion. Immunodeficiency should be ruled out in patients with infections due to B. cepacia.
ACCESSION #
40089373

 

Related Articles

  • Molecular Analysis of Four Cases of Chronic Granulomatous Disease Caused by Defects in NCF-2: The Gene Encoding the p67-phox. Badalzadeh, Mohsen; Fattahi, Fatemeh; Fazlollahi, Mohammad Reza; Tajik, Shaghayegh; Bemanian, Mohammad Hassan; Behmanesh, Fatemeh; Movahedi, Massoud; Houshmand, Massoud; Pourpak, Zahra // Iranian Journal of Allergy, Asthma & Immunology;2012, Vol. 11 Issue 4, p340 

    Chronic granulomatous disease (CGD), a rare inherited primary immunodeficiency disorder, is caused by mutation in any one of the genes encoding components of nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase enzyme. NCF2 gene (encoding P67-phox component) is one of them and its...

  • chronic granulomatous disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p449 

    A definition of the term "chronic granulomatous disease" or CGD which refers to a rare, congenital and fatal immunodeficiency characterized by a white blood cell defect is presented.

  • Mycetoma: A Review. Lichon, Vanessa; Khachemoune, Amor // American Journal of Clinical Dermatology;2006, Vol. 7 Issue 5, p315 

    Mycetoma is a chronic granulomatous infection that is present worldwide and endemic in tropical and subtropical regions. The infection is caused by the traumatic inoculation of a fungus (eumycetoma) or a bacterium (actinomycetoma) and generally remains localized, causing cutaneous and...

  • An unusual cause of granulomatous disease. Mclean-Tooke, Andrew P. C.; Aldridge, Catherine; Gilmour, Kimberley; Higgins, Bernard; Hudson, Mark; Spickett, Gavin P. // BMC Clinical Pathology;2007, Vol. 7, p1 

    Background: Chronic granulomatous disease (CGD) is an inherited disorder of phagocytic cells caused by an inability to generate active microbicidal oxygen species required kill certain types of fungi and bacteria. This leads to recurrent life-threatening bacterial and fungal infections with...

  • Educational paper. Berg, J.; Kuijpers, Taco // European Journal of Pediatrics;Nov2011, Vol. 170 Issue 11, p1369 

    The neutrophilic granulocyte (neutrophil) is the most important cellular component of the innate immune system. A total absence of neutrophils or a significant decrease in their number leads to severe immunodeficiency. A mature neutrophil, released from the bone marrow, should be able to migrate...

  • Chronic Granulomatous Disease in Childhood. Barese, Cecilia; Goebel, W. Scott // Current Pediatric Reviews;2006, Vol. 2 Issue 1, p63 

    Chronic granulomatous disease (CGD) is a genetic immunodeficiency that commonly presents in infancy and early childhood. Currently, life expectancy is beyond the fourth decade of life if the disease is promptly diagnosed and treated. CGD is characterized by increased susceptibility to recurrent...

  • Nonparametric prediction of event times in randomized clinical trials. Ying, Gui-Shuang; Heitjan, Daniel F; Chen, Tai-Tsang // Clinical Trials;2004, Vol. 1 Issue 4, p352 

    In clinical trials with planned interim analysis, it can be valuable for logistical reasons to predict the times of landmark events such as the 50th and 100th event. Bagiella and Heitjan (Stat Med 2001; 20: 2055 � 63) proposed a parametric prediction model for failure-time outcomes assuming...

  • A Novel Bacterium Associated with Lymphadenitis in a Patient with Chronic Granulomatous Disease. Greenberg, David E.; Li Ding; Zelazny, Adrian M.; Stock, Frida; Wong, Alexandra; Anderson, Victoria L.; Miller, Georgina; Kleiner, David E.; Tenorio, Allan R.; Brinster, Lauren; Dorward, David W.; Murray, Patrick R.; Holland, Steven M.; Cossart, Pascale // PLoS Pathogens;Apr2006, Vol. 2 Issue 4, pe28 

    Chronic granulomatous disease (CGD) is a rare inherited disease of the phagocyte NADPH oxidase system causing defective production of toxic oxygen metabolites, impaired bacterial and fungal killing, and recurrent life-threatening infections. We identified a novel gram-negative rod in excised...

  • Itraconazole to Prevent Fungal Infections in Chronic Granulomatous Disease. Gallin, John I.; Alling, David W.; Malech, Harry L.; Wesley, Robert; Koziol, Deloris; Marciano, Beatriz; Eisenstein, Eli M.; Turner, Maria L.; DeCarlo, Ellen S.; Starling, Judith M.; Holland, Steven M. // New England Journal of Medicine;6/12/2003, Vol. 348 Issue 24, p2416 

    Background: Chronic granulomatous disease is a rare disorder in which the phagocytes fail to produce hydrogen peroxide. The patients are predisposed to bacterial and fungal infections. Prophylactic antibiotics and interferon gamma have reduced bacterial infections, but there is also the danger...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics